Topical corticosteroids: quality control considerations
- PMID: 1428466
- DOI: 10.1111/j.1365-4362.1992.tb04011.x
Topical corticosteroids: quality control considerations
Abstract
A simple procedure is developed, which can be used as a quality control test. The method utilizes commercially available diffusion cell assembly, synthetic membrane, and an appropriate receptor phase. The amount of drug released over time is determined using an HPLC method. From this, the drug release rate, flux, microgram/cm2/min0.5 is calculated. This drug release rate can serve as a good quality control test to assure batch-to-batch uniformity.
Similar articles
-
In vitro release of hydrocortisone from topical preparations and automated procedure.Pharm Res. 1991 Jan;8(1):55-9. doi: 10.1023/a:1015826205930. Pharm Res. 1991. PMID: 2014209
-
New approaches to assess topical corticosteroid bioequivalence: pharmacokinetic evaluation.Int J Dermatol. 1992 Oct;31 Suppl 1:14-20. doi: 10.1111/j.1365-4362.1992.tb04007.x. Int J Dermatol. 1992. PMID: 1428461
-
Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products.Pharm Dev Technol. 1999 Aug;4(3):377-85. doi: 10.1081/pdt-100101373. Pharm Dev Technol. 1999. PMID: 10434283
-
The relevance of polymeric synthetic membranes in topical formulation assessment and drug diffusion study.Arch Pharm Res. 2012 Mar;35(4):579-93. doi: 10.1007/s12272-012-0401-7. Epub 2012 May 3. Arch Pharm Res. 2012. PMID: 22553050 Review.
-
Topical corticosteroids: a review of properties and principles in therapeutic use.Nurse Pract Forum. 1999 Jun;10(2):95-105. Nurse Pract Forum. 1999. PMID: 10542586 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources